1. Home
  2. CFFI vs VYGR Comparison

CFFI vs VYGR Comparison

Compare CFFI & VYGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo C&F Financial Corporation

CFFI

C&F Financial Corporation

HOLD

Current Price

$72.85

Market Cap

236.4M

Sector

Finance

ML Signal

HOLD

Logo Voyager Therapeutics Inc.

VYGR

Voyager Therapeutics Inc.

HOLD

Current Price

$3.88

Market Cap

194.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CFFI
VYGR
Founded
1927
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
236.4M
194.0M
IPO Year
1996
2015

Fundamental Metrics

Financial Performance
Metric
CFFI
VYGR
Price
$72.85
$3.88
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$17.00
AVG Volume (30 Days)
1.9K
466.5K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
2.53%
N/A
EPS Growth
37.94
N/A
EPS
8.29
N/A
Revenue
$140,841,000.00
$10,135,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$71.77
P/E Ratio
$8.79
N/A
Revenue Growth
10.63
N/A
52 Week Low
$53.14
$2.65
52 Week High
$80.99
$5.55

Technical Indicators

Market Signals
Indicator
CFFI
VYGR
Relative Strength Index (RSI) 44.36 51.04
Support Level $66.92 $3.73
Resistance Level $72.90 $4.43
Average True Range (ATR) 1.33 0.24
MACD -0.56 0.04
Stochastic Oscillator 19.37 58.26

Price Performance

Historical Comparison
CFFI
VYGR

About CFFI C&F Financial Corporation

C&F Financial Corp is an American bank holding company. The company through its subsidiaries offers banking and related financial services to both individuals and businesses. It operates in three business activities: Community Banking, Mortgage Banking, and Consumer Finance. It mainly provides a range of lending activities, which include residential mortgage loans, commercial real estate loans, non-prime automobile lending, land acquisition, and development loans, and consumer loans. The company generates maximum of its revenue from the Community Banking segment.

About VYGR Voyager Therapeutics Inc.

Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform TRACER enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. Its pipeline of programs include, Anti-tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy (siRNA), FXN Gene Therapy among others.

Share on Social Networks: